Reproductive · PANCE / PANRE

Cryptorchidism (Undescended Testis)

Failure of one or both testes to descend into the scrotum by 6 months of age.

Also known as: cryptorchidism, undescended testis, UDT, undescended testicle

Overview

Failure of one or both testes to reach the dependent portion of the scrotum. Classified as palpable (in the inguinal canal or high scrotal position) or non-palpable (intra-abdominal, ectopic, or absent/vanishing testis).

Epidemiology

Present in ~3% of full-term and 30% of preterm male infants; most descend spontaneously by 3-6 months. Persistent cryptorchidism affects ~1% of boys at 1 year. Higher in low birth weight, prematurity, and twins.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Cryptorchidism (Undescended Testis) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Prematurity, low birth weight, small-for-gestational-age
  • Family history of cryptorchidism
  • Maternal smoking, exposure to endocrine-disrupting chemicals
  • Genetic syndromes: Klinefelter, Prader-Willi, Kallmann, persistent mullerian duct syndrome, androgen insensitivity
  • Disorders of sex development (DSD) — especially if bilateral non-palpable

Pathophysiology

Testicular descent occurs in two phases: trans-abdominal (mediated by INSL3/RXFP2) and inguinoscrotal (androgen-dependent, mediated by genitofemoral nerve and CGRP). Disruption of either step results in cryptorchidism.

Clinical presentation

Symptoms

  • Usually asymptomatic; identified at newborn or well-child exam

Signs / physical exam

  • Inability to palpate the testis in the scrotum in a warm relaxed environment
  • Empty hemiscrotum (possibly hypoplastic)
  • Distinguish from retractile testis by warming the child and gentle manipulation

Differential diagnosis

  • Retractile testis — Hyperactive cremasteric reflex; testis can be manipulated into the scrotum and remains briefly — not cryptorchidism, no surgery needed but monitor (some become ascending testes)
  • Ascending testis (acquired UDT) — Previously fully descended testis later found out of the scrotum — managed similarly to congenital UDT with orchiopexy
  • Ectopic testis — Outside normal path of descent (perineal, femoral, contralateral scrotal); requires surgery
  • Anorchia / vanishing testis — Non-palpable unilateral testis; MIS and testosterone production absent on stimulation; confirmed at surgery

Diagnostic workup

Diagnostic criteria

Clinical examination — testis not present in the scrotum at >=6 months corrected age.

Labs

  • Bilateral non-palpable testes: karyotype, 17-hydroxyprogesterone (to exclude congenital adrenal hyperplasia in 46,XX virilized female) — DSD evaluation
  • Anti-Mullerian hormone (AMH) and inhibin B levels can confirm presence or absence of functional testicular tissue (anorchia evaluation)
  • hCG stimulation test in select cases

Imaging

  • Routine ultrasound is NOT recommended (poor sensitivity and specificity, does not change management) per AUA
  • If non-palpable: diagnostic laparoscopy is the gold standard to locate or confirm absence of intra-abdominal testis

Diagnostic algorithm

flowchart TD
  A[Newborn male, empty scrotum] --> B[Observe to 6 mo]
  B --> C{Descended<br/>by 6 mo?}
  C -->|Yes| D[Routine well-child care]
  C -->|No| E[Refer to pediatric urology]
  E --> F{Palpable?}
  F -->|Yes| G[Inguinal orchiopexy<br/>between 6-18 mo]
  F -->|No, unilateral| H[Diagnostic laparoscopy]
  H -->|Intra-abdominal| I[Orchiopexy<br/>+/- Fowler-Stephens]
  H -->|Absent / vanishing| J[Document, no further surgery]
  F -->|No, bilateral| K[DSD workup<br/>karyotype, 17-OHP, AMH, hCG stim]
  K --> H
Evaluation and management algorithm for cryptorchidism.

Treatment

First-line

  • Observation in first 6 months of life — most descend spontaneously
  • Orchiopexy between 6 and 18 months of age if testis has not descended (AUA recommends by 18 months; earlier surgery between 6-12 months may improve fertility and reduce malignancy risk)
  • Standard inguinal orchiopexy for palpable testis with hernia sac high ligation
  • Two-stage Fowler-Stephens orchiopexy for high intra-abdominal testes — first stage clipping of testicular vessels, second stage mobilization 6 months later
  • Hormonal therapy (hCG, GnRH) is NOT recommended by AUA — low efficacy and not durable

Post-pubertal / adult cryptorchidism

  • Orchiectomy generally recommended over orchiopexy after puberty due to higher malignancy risk and very low fertility potential in long-standing UDT
  • Bilateral post-pubertal cryptorchidism is managed individually, balancing testosterone production, fertility, and malignancy risk

Second-line / adjunct

  • Testicular prostheses may be offered after orchiectomy

Complications

  • Subfertility/infertility (greater in bilateral, intra-abdominal, and late-corrected cases)
  • Testicular germ cell cancer — RR ~2-8x for cryptorchid testes; orchiopexy reduces but does not eliminate risk and allows surveillance
  • Testicular torsion (cryptorchid testes are at increased risk)
  • Associated inguinal hernia (high incidence)
  • Psychological impact

PANCE pearls

  • Refer to pediatric urology by 6 months of age if testis has not descended — definitive surgery before 18 months reduces complications.
  • Imaging is NOT useful in cryptorchidism — diagnostic laparoscopy is the gold standard for non-palpable testes.
  • Bilateral non-palpable testes in a phenotypic male require urgent evaluation for disorder of sex development, including CAH (potentially virilized 46,XX female with salt-wasting crisis).
  • Orchiopexy reduces but does not eliminate testicular cancer risk; lifelong self-examination education is recommended.
  • A retractile testis is a normal variant and does not require surgery, but should be followed because a subset become ascending and require eventual repair.

References

  • AUA 2014 — AUA Guideline: Evaluation and Treatment of Cryptorchidism (Kolon et al., J Urol 2014)
  • EAU/ESPU — EAU/ESPU Guidelines on Paediatric Urology — Cryptorchidism
  • AAP — American Academy of Pediatrics Section on Urology resources

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.